Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2026: Emerging Trends and Growth Scenarios
Uncover key drivers, emerging technologies, and competitive movements shaping the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market in 2026, and what figure is it projected to hit by 2030?
The market size for advanced therapy medicinal products contract development and manufacturing organizations (cdmo) has experienced rapid expansion recently. This market is projected to expand from $6.2 billion in 2025 to $7.24 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. Historically, this expansion can be linked to the restricted availability of specialized CDMO services, increased research and development investment in advanced therapies, the early adoption of gene and cell therapies, a rising prevalence of complex diseases, and the proliferation of small biotech startups.
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market size is projected to experience substantial expansion in the coming years. It is anticipated to grow to $12.55 billion in 2030, showing a compound annual growth rate (CAGR) of 14.8%. This projected growth throughout the forecast period can be attributed to enhancements in scalable manufacturing technologies, an increase in collaborations between cdmos and pharmaceutical companies, the expansion of autologous and allogeneic therapies, a rising global demand for personalized medicine, and market penetration into emerging regions. During this same forecast period, significant trends are expected to include an escalating demand for cdmo services in the development of advanced therapies, the broader application of gene, cell, and tissue engineered therapies, an intensified focus on regulatory compliance and quality standards, an increase in outsourced manufacturing for biopharmaceutical entities, and the adoption of adaptable and scalable manufacturing platforms.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp
Which Drivers Are Affecting Market Participation In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
An escalating volume of clinical trials is anticipated to stimulate the expansion of the advanced therapy medicinal products CDMO market moving forward. These trials are human-based investigations assessing the safety and effectiveness of various medical interventions, including drugs, therapies, devices, or preventive strategies. The number of clinical trials is escalating due to the growing need for innovative treatments and to tackle an increasing global disease burden. Consequently, the adoption of advanced therapy medicinal products leads to a heightened demand for CDMO manufacturing services, which utilize specialized knowledge and facilities. Data from clinical trials plays a crucial role in refining manufacturing processes, ensuring scalability, and upholding quality to satisfy broader clinical and commercial requirements. For instance, in July 2024, the Royal Pharmaceutical Society, a UK-based professional membership body, reported that 349,019 individuals were recruited for clinical trials in the UK during 2023/2024, marking an increase from 342,390 people in 2022/2023. Thus, the rising count of clinical trials is fueling the development of the advanced therapy medicinal products CDMO market.
What Segment Classifications Make Up The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology
Subsegments:
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs
Which Trends Are Expected To Influence The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In The Upcoming Years?
Leading companies in the advanced therapy medicinal products CDMO market are developing advanced cell therapy manufacturing services to resolve critical issues in cell therapy production and expedite their partners’ development activities. Cell therapy manufacturing services are offerings from contract development and manufacturing organizations that span from early preclinical development to late-stage clinical trials and ultimate commercialization. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech firm that transforms cells into solutions, launched PluriCDMO, a new business unit dedicated to cell therapy manufacturing. This unit utilizes a patented bioreactor system that facilitates 3D cell multiplication, thereby enabling the production of various cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO intends to provide high-quality, vital medicines to patients while maintaining consistent batch-to-batch quality in a scalable and cost-effective manner within good manufacturing practice settings.
Which Major Firms Are Strengthening Their Position In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15719&type=smp
Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Market Report 2026
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
